{"entity":{"type":"insider","cik":"0001277161","url":"/insider/0001277161","json_url":"/insider/0001277161.json","name":"SIDRANSKY DAVID","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":4,"first":"2014-12-03","last":"2021-03-08","span_basis":"filed_date"},"name_variants":[{"name":"SIDRANSKY DAVID","source":"filing","n_filings":4,"first_seen":"2014-12-03","last_seen":"2021-03-08"}],"transactions":[{"id":5236711,"accession":"0000899243-21-010346","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-8","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4.0,"shares_display":"4","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":46.24,"total_display":"46.24","shares_owned_after":250.0,"shares_owned_after_display":"250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2021-03-08","scope":"insider"},{"id":5236707,"accession":"0000899243-21-010346","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-7","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1.0,"shares_display":"1","price_per_share":10.7,"price_display":"10.70","price_state":"stated","total_value":10.7,"total_display":"10.70","shares_owned_after":246.0,"shares_owned_after_display":"246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2021-03-08","scope":"insider"},{"id":5236702,"accession":"0000899243-21-010346","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-6","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10.0,"shares_display":"10","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":100.7,"total_display":"100.70","shares_owned_after":245.0,"shares_owned_after_display":"245","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2021-03-08","scope":"insider"},{"id":5236698,"accession":"0000899243-21-010346","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-5","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5.0,"shares_display":"5","price_per_share":11.07,"price_display":"11.07","price_state":"stated","total_value":55.35,"total_display":"55.35","shares_owned_after":235.0,"shares_owned_after_display":"235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2021-03-08","scope":"insider"},{"id":5236694,"accession":"0000899243-21-010346","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-4","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4.0,"shares_display":"4","price_per_share":11.86,"price_display":"11.86","price_state":"stated","total_value":47.44,"total_display":"47.44","shares_owned_after":230.0,"shares_owned_after_display":"230","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-17","filed_date":"2021-03-08","scope":"insider"},{"id":5236687,"accession":"0000899243-21-010346","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-3","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1.0,"shares_display":"1","price_per_share":9.6,"price_display":"9.60","price_state":"stated","total_value":9.6,"total_display":"9.60","shares_owned_after":226.0,"shares_owned_after_display":"226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2021-03-08","scope":"insider"},{"id":4521002,"accession":"0001493152-21-000724","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001493152-21-000724","line_url":"/filing/0001493152-21-000724#line-4","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Orgenesis Inc.","issuer_ticker":"ORGS","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10.0,"shares_display":"10","price_per_share":6.98,"price_display":"6.98","price_state":"stated","total_value":69.8,"total_display":"69.80","shares_owned_after":180.0,"shares_owned_after_display":"180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2021-01-11","scope":"insider"},{"id":4520998,"accession":"0001493152-21-000724","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-21-000724","line_url":"/filing/0001493152-21-000724#line-3","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Orgenesis Inc.","issuer_ticker":"ORGS","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70.0,"shares_display":"70","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":417.2,"total_display":"417.20","shares_owned_after":170.0,"shares_owned_after_display":"170","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2021-01-11","scope":"insider"},{"id":5236683,"accession":"0000899243-21-010346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-2","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25.0,"shares_display":"25","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":375.5,"total_display":"375.50","shares_owned_after":225.0,"shares_owned_after_display":"225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2021-03-08","scope":"insider"},{"id":4520994,"accession":"0001493152-21-000724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-000724","line_url":"/filing/0001493152-21-000724#line-2","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Orgenesis Inc.","issuer_ticker":"ORGS","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90.0,"shares_display":"90","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":531.0,"total_display":"531.00","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2021-01-11","scope":"insider"},{"id":5236675,"accession":"0000899243-21-010346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-010346","line_url":"/filing/0000899243-21-010346#line-1","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Ayala Pharmaceuticals, Inc.","issuer_ticker":"AYLA","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":15.27,"price_display":"15.27","price_state":"stated","total_value":3054.0,"total_display":"3,054.00","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2021-03-08","scope":"insider"},{"id":4520983,"accession":"0001493152-21-000724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-000724","line_url":"/filing/0001493152-21-000724#line-1","is_derivative":false,"issuer_cik":"0001277161","issuer_name":"Orgenesis Inc.","issuer_ticker":"ORGS","issuer_name_source":null,"issuer_url":"/issuer/0001277161","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10.0,"shares_display":"10","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":54.2,"total_display":"54.20","shares_owned_after":10.0,"shares_owned_after_display":"10","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2021-01-11","scope":"insider"},{"id":2718699,"accession":"0001493152-16-012172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-16-012172","line_url":"/filing/0001493152-16-012172#line-2","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11404.0,"shares_display":"11,404","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":169349.4,"total_display":"169,349.40","shares_owned_after":80355.0,"shares_owned_after_display":"80,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-09","filed_date":"2016-08-10","scope":"insider"},{"id":2718694,"accession":"0001493152-16-012172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-16-012172","line_url":"/filing/0001493152-16-012172#line-1","is_derivative":false,"issuer_cik":"0001100397","issuer_name":"Advaxis, Inc.","issuer_ticker":"ADXS","issuer_name_source":null,"issuer_url":"/issuer/0001100397","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11404.0,"shares_display":"11,404","price_per_share":15.17,"price_display":"15.17","price_state":"stated","total_value":172998.68,"total_display":"172,998.68","shares_owned_after":91759.0,"shares_owned_after_display":"91,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-08","filed_date":"2016-08-10","scope":"insider"},{"id":6740615,"accession":"0001144204-14-072144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-072144","line_url":"/filing/0001144204-14-072144#line-1","is_derivative":false,"issuer_cik":"0001208261","issuer_name":"IMMUNE PHARMACEUTICALS INC","issuer_ticker":"IMNP","issuer_name_source":null,"issuer_url":"/issuer/0001208261","owner_cik":"0001277161","owner_name":"SIDRANSKY DAVID","owner_url":"/insider/0001277161","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10400.0,"shares_display":"10,400","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":26000.0,"total_display":"26,000.00","shares_owned_after":18290.0,"shares_owned_after_display":"18,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-12-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001797336","name":"Ayala Pharmaceuticals, Inc.","url":"/issuer/0001797336","role":"Director","n_filings":1,"first_seen":"2021-03-08","last_seen":"2021-03-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001460602","name":"Orgenesis Inc.","url":"/issuer/0001460602","role":"Director","n_filings":1,"first_seen":"2021-01-11","last_seen":"2021-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001100397","name":"Advaxis, Inc.","url":"/issuer/0001100397","role":"Director","n_filings":1,"first_seen":"2016-08-10","last_seen":"2016-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001208261","name":"IMMUNE PHARMACEUTICALS INC","url":"/issuer/0001208261","role":"Director","n_filings":1,"first_seen":"2014-12-03","last_seen":"2014-12-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001277161","retrieved_at":"2026-08-21T21:28:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}